Healio

Director of FDA Ophthalmology Division offers insight on clinical trial design

If researchers hope to lean on data from a single trial for therapeutic approval, it is important to communicate with the FDA ...

The Other Side of the Nuclear Renaissance: How Domestic Uranium Lands on the Pre-Feasibility Calendar

Issued on behalf of Eagle Nuclear Energy Corp.As the SMR and small-reactor build-out accelerates and federal directives mandate space-based ...
BMJ Open Sport & Exercise Medicine

Early adapted physical activity to prevent and manage aromatase inhibitor-induced musculoskeletal pain in breast cancer: protocol for a hybrid effectiveness-implemen…

Aromatase inhibitors are the standard adjuvant hormone therapy for postmenopausal women with hormone-sensitive breast cancer.
JD Supra

CMS and FDA Propose Major Changes for Breakthrough Devices with Proposed Repeal of NTAP “Alternative Pathway” and New “RAPID” Coverage Pathway

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) recently issued two related proposals that, taken together, would significantly alter the pathways ...

AB Science reports its revenues for the year 2025 and provides an update on its activities

PRESS RELEASEAB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIODFinancial and ...

Praxis Precision Medicines, Inc. (PRAX) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Bank of America Global Healthcare Conference 2026 May 12, 2026 7:20 PM EDTCompany ParticipantsMegan Sniecinski ...
urologytimes

Oral Selective FGFR3 Inhibition in Urothelial Carcinoma: Opportunities in Intermediate Risk Non-Muscle Invasive Bladder Cancer and Low Grade Upper Tract Urothelial Carcinoma

Recent progress in the treatment of advanced urothelial carcinoma (UC) has improved the outlook for patients with metastatic disease. However, UC in the earlier stages remains a major source of ...
Business Wire

Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
IEEE

Event-Triggered Deep Reinforcement Learning Using Parallel Control: A Case Study in Autonomous Driving

Abstract: This paper utilizes parallel control to investigate the problem of event-triggered deep reinforcement learning and develops an event-triggered deep Q-network (ETDQN) for decision-making of ...
ahajournals.org

Effects of Increasing Total Fruit Intake With Avocado and Mango on Endothelial Function and Cardiometabolic Risk Factors in Adults With Prediabetes

Low fruit intake is a global risk factor for cardiometabolic diseases. This study sought to investigate vascular and metabolic effects of increasing total and select fruit intake in adults with ...
ebm.bmj

Incomplete reporting and spin in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study

3 The Affiliated Guangzhou Hospital of TCM of Guangzhou University of Chinese Medicine, Guangzhou, China 4 The Affiliated Brain Hospital, Guangzhou Medical University, Key Laboratory of Neurogenetics ...
ascopubs.org

Randomized Parallel-Group Phase II Study (NEOTERIC) of Atezolizumab With or Without Tiragolumab After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study This randomized, parallel-group, phase II study ...